​​​
  1. Dealtracker

Dealtracker

According to Grant Thornton, private equity (PE) investments witnessed a year-on-year increase of 58% in volume terms and 48% in value terms, driven by four large deals during May.

Updated: June 11, 2015 12:47 AM

According to Grant Thornton, private equity (PE) investments witnessed a year-on-year increase of 58% in volume terms and 48% in value terms, driven by four large deals during May. Also, PE deals increased 66% year on year, recording large investments in sectors like IT & ITES, banking and financial services, pharma, real estate and manufacturing. However, M&A deal activity in May declined, both in terms of volume and value. There were 115 deals worth $3.3 billion, which was higher in terms of volume (21%) but lower in terms of value (37%) on a year on year basis. The decline can be attributed to lower domestic and inbound M&A deal values, primarily due to fewer big-ticket deals this month.

deal

Grant Thornton said YTD May 2015, M&A and PE together accounted for 23 deals valued over $100 million each and 20 deals over $50 million each. The month witnessed the sixth-largest overseas acquisition in the pharma sector by an Indian company. In May, Strides Arcolabs acquired Aspen Pharmacare’s generic drug business in Australia for $300 million, the sixth-largest overseas acquisition in the pharma sector.

For Updates Check Company News; follow us on Facebook and Twitter

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Go to Top